Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
With The first BDD submittal, no one really knew what it was. Many probably thought it was another form of ide to start human trials.
Now anyone that’s been following since then or anyone that actually knows what the bdd is all about knows that right now it really doesn’t mean squat until ide approval and that’s why there was little excitement about it.
Once ide approval hits then the BDD comes into play with expedited meetings and reviews of the human trials, so with that the phases of human trials won’t take nearly as long. Very good news here but don’t matter until ide is approved.
So unfortunately only news that’s going to move this is an actual PR that has to have one or all of this information
1. PR that actually Gives us a hard date when they plan to submit the ide. This won’t make it explode but I believe it will get things moving in the right direction with the share price.
2. The obvious PR stating that they have submitted the IDE.
No other good news will get this moving.
Well maybe except announcing a contract with a nation wide vet hospital for isopet and stating that every location within 6 months will be able to provide isopet. Even this news will gain only a little traction.
The Cost of isopet depends on how many treatments will be given in that particular day and at the clinic.
I believe for one treatment it’s around $10,000.
If multiple pets are treated at the same clinic on the same day I believe the price drops considerably to around 7-8 thousand per pet.
As for a breakdown of the percentages of where the money goes as far as I know has never been released.
Also there are pet insurance companies that will cover this procedure as well.
I agree completely, I was just stating that there’s brokers out there that are restricted or just won’t invest in anything below a dollar. There’s a lot of individual traders that are the same way.
Also remember there’s some brokers that can’t invest in anything below certain amounts or won’t.
IDE approval. So the faster we get above a dollar the better all the way around for everyone
Omg 2 million shares and we are still under 400 million outstanding shares. That’s actually amazing. For an otc that is pretty damn good. Hmmm let’s see getting ready to submit ide application and more than likely get approved to start human trials. So the dilution is coming from the reg A offering. Not a big deal
So I forgot a few things, big fucking deal. Go cry a River.
They do have around 1.5-1.8 million cash on hand which in my opinion should be enough to get through phase 1 clinical trials. If they get ide approved and can start asap.
However they did just do an offering at .065 to raise around 3.2 million dollars. Which is odd because they just amended an existing offering just a few weeks ago.
So Right now there’s a few confusing things going on right now. Why the new offering for less and why was it done just a few weeks after the amendment.
If you haven’t figured out don’t believe a couple of posters on here. They have a personal agenda and even if you ask a question they don’t answer directly or at all.
Lots of longs invested here and unfortunately some of have been here for 5 plus years. Nuts I know. In short there’s every bit of 100 million shares held in longs hands.
They didn’t meet all the criteria for the BDD the first time.
Also Radiogel is in the EFS IDE process.
In short it takes a longer going this route because we are essentially given a set of board members(7 or 8 personnel) from the fda to review the data, and questions from the Radiogels team. By going this route alone increases the ide approval to 75 percent.
Problem going this route the board can ask for new data/tests at anytime. A good/bad route but with every additional request it’s less of a chance for denial.
Also there are John’s Hopkins and Mayo Clinic’s doctors that sit on the meetings with Doctor Korenko with Radiogel.
To prolong things, they changed the formula enough to be able to get away from leasing fees from Battale. By doing this some tests have been requested to be done again.
Your opinion not facts
My apologies, didn’t see that. Very odd considering that they just made amendments a few weeks ago
You probably better look on otcmarkets, that information you posted is wrong for the offering
I bet all the traders that sold for tax loss and we’re planning on getting back in around.05 are sick to their stomachs now.
They do quarterly updates now and usually do it with in the first 2 weeks of the new quarter, So next one should be in the first 2 weeks of January.
Lol, oh I know. Honestly wouldn’t give him that much credit.
Hmmm quarterly update, meaning they will tell us everything that they choose to tell us in the quarterly update. Everything from isopet to what’s going on with the ide.
You’re wrong again There’s a very clear path for the ide which is the ESF ide submittal. It’s called the esf program where the fda tells them what to do, it is not a speedy process, the fda can bring up suggestions at anytime.
Have you forgotten that they were told by the fda to take this path before submitting the ide. Which is a pathway to better approval odds of an ide.
No pathway you’re hilarious, I love reading lies they make me laugh.
You really need to get a new hobby or follow a new company, only 2 maybe 3 people on this board actually believe the bs you spew repeatedly on this board.
He stated everything will be in the quarterly update that will be put out in the 2nd half of October.
Lmao now that’s funny
Pretty sure the reason is to keep people from bothering them when they have no answers yet.
In short he has no clue what’s going on or how things work in the otc
Meeting September 29th this Friday. Doctor is being tight lipped about everything so we won’t hear anything until sometime next week.
You are correct, RDGL has plenty of runway left, they have only used 369 million shares of the 900million. If needed they can increase the AS fairly easily. Which I’m positive they won’t need to.
Some traders on here need to go back to the nasdaq because they obviously know nothing about how the otc works.
He forgets that’s also when the bdd fda review team suggested that the doctor goes through the EFS IDE program which the doctor took that advice because it increased the approval chances to 75-80%.
The doctor also said that going this route would take more time because the fda would be holding their hand. But some people forget this.
What one denies is that the doctor also changed to a EFS IDE which he clearly stated was a path suggested by the fda board members that over saw the bdd submittal.
Also with this path the doctor also stated that this path will take longer because the FDA will be holding their hand and will bring up at different times what type of testing and data the fda will like to see in the final ide submittal.
So the main reason this is taking so long is because the doctor changed paths suggested by the FDA which anyone that’s been following this for awhile knows that, but unfortunately there are a few that don’t mention that part.
Also most forget that the doctor has been communicating with the FDA since he took over which is where the 5yrs of communication has come from.
We are closer than ever to submitting the IDE patients is key with this one.
Hard to believe that there’s actually traders that have no confidence in a company that supposedly still own shares or has been buying shares. I myself, if I don’t believe in a company I stay far away from it.
But I believe in the doctor and seen him keep this company from going bankrupt and keeping the process moving forward. I’m in until 100% approval.
Honestly that could easily be the price prediction for ide approval. Obviously that all depends on a lot of factors.
I’m guessing around the $2-$5 range by the time phase 1 human trials start.
Again a lot of factors involved. I think the biggest one is if they can give a actual start date and a rough timeline for phase 1.
Hmmm that’s even more interesting. That makes no sense at all.
So my original guess is probably right. Someone with a lot of shares is propping this up, and isn’t to worried if he sells some, more than likely bought them between .01and .05 so he’s still making a profit if this is the case. I salute him, otherwise I’m pretty sure we would be back around low .05s.
Odd that a MM would be holding up the price. Just when you think you have seen it all. Very odd
And super thin to .085
It’s possible it could be a long with a shit load of shares and is putting the wall up to keep it up above .06. And help screw the shorts
I agree with that but at the same time the trader isn’t letting it fall below 6.
With the low volume they could easily get cheaper shares if he removed the wall. Possibly
Interesting trading going on
It’s back at .0601 at 700000 shares. Whoever this is doesn’t want it to fall below 6
The doc will be getting a response the week before on the genotoxicity protocol and whatever else.
So possibly a very small possibility that the fda decides not to have the meeting the 29th and allows them to submit the ide application when they get whatever they need from the geno testing.
A very small possibility this will happen but it’s still a possibility that it could.
My opinion I don’t see to much happening this week, I’ve been wrong before but I believe next week we will hopefully start seeing the move upward again.
Especially since it seems to me anyway that the Mayo and JHU are pretty much running the ide and will be in charge of human trials.
So what will the doc be doing, he’ll be pushing isopet and possibly still working on things for the international side of things. Just my opinion of course
50-100 is reasonable on the low end. Remember at least a 1/3 of the float is locked up in longs hands, maybe even as high as 2/3rds.
Anyone following this and has actually did the research they know this also has a 75% or better chance of getting approved for human trials, by doing the efs ide.
So in my opinion pr of ide application gets submitted this hits big and keeps going up, with some pullbacks here and there. Then goes even higher on approval, then the final up move will be if they can release a start date for human trials,
Nice to see volume picking up, hopefully it continues as well as the price. Time will tell
969000 volume so far according to Schwab, is that close to others
They had to reschedule because of scheduling conflicts with the FDA.
It was originally scheduled earlier in the month, the FDA screwed up and made them reschedule
That is interesting 2 days in a row, dropping a pr now would be perfect timing